Mechanisms of tumor necrosis factor-alpha-induced leaks in intestine epithelial barrier

Cytokine

Volumn 59, Issue 2, 2012, Pages 264-272

  He, Fang ^a   Peng, Jing ^a   Deng, Xiao lu ^a   Yang, Li fen ^a   Camara, Aboubacar Damayé ^a   Omran, Ahmed ^a   Wang, Guo li ^a   Wu, Li wen ^a   Zhang, Ci Liu ^a   Yin, Fei ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

MLCK; NF B; Permeability; Tight junction; Tumor necrosis factor alpha

Indexed keywords

F ACTIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN KINASE; OCCLUDIN; PHALLOIDIN; PROTEIN ZO1; RHODAMINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; GENE SILENCING; GENETIC TRANSFECTION; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REPORTER GENE; STAINING; TIGHT JUNCTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ACTINS; CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; EPITHELIUM; HUMANS; I-KAPPA B PROTEINS; INTESTINES; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN KINASE; NF-KAPPA B; PHOSPHORYLATION; PLASMIDS; RNA, SMALL INTERFERING; TIGHT JUNCTIONS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862324885     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.04.008     Document Type: Article

References (41)

1. Van Deventer S.J. Tumour necrosis factor and Crohn's disease. Gut 1997, 40:443-448.
2. Braegger C.P., Nicholls S., Murch S.H., Stephens S., MacDonald T.T. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 1992, 339:89-91.
3. Assasi N., Blackhouse G., Xie F., Marshall J.K., Irvine E.J., Gaebel K., et al. Patient outcomes after anti TNF-alpha drugs for Crohn's disease. Expert Rev Pharmacoecon Outcomes Res 2010, 10:163-175.
4. Al-Subeihe I., Nielsen O.H. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn disease. A survey of a Cochrane review. Ugeskr Laeger 2008, 170:4130-4134.
5. Capaldo C.T., Nusrat A. Cytokine regulation of tight junctions. Biochim Biophys Acta 2009, 1788:864-871.
6. Bruewer M., Luegering A., Kucharzik T., Parkos C.A., Madara J.L., Hopkins A.M., et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 2003, 171:6164-6172.
7. Buhner S., Buning C., Genschel J., Kling K., Herrmann D., Dignass A., et al. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?. Gut 2006, 55:342-347.
8. Soderholm J.D., Peterson K.H., Olaison G., Franzen L.E., Westrom B., Magnusson K.E., et al. Epithelial permeability to proteins in the noninflamed ileum of Crohn's disease?. Gastroenterology 1999, 117:65-72.
9. Breslin N.P., Nash C., Hilsden R.J., Hershfield N.B., Price L.M., Meddings J.B., et al. Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease. Am J Gastroenterol 2001, 96:2934-2938.
10. Wang G.L., Yin J.H., Mao D.A., He F., Yin F. Tumor necrosis factor-α increases the para-cellular permeability of Caco-2 cell monolayers in vitro. World Chin J Digestol 2010, 18:942-946.
11. Zeissig S., Bojarski C., Buergel N., Mankertz J., Zeitz M., Fromm M., et al. Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment. Gut 2004, 53:1295-1302.
12. Shen L., Black E.D., Witkowski E.D., Lencer W.I., Guerriero V., Schneeberger E.E., et al. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci 2006, 119:2095-2106.
13. Costantini T.W., Loomis W.H., Putnam J.G., Kroll L., Eliceiri B.P., Baird A., et al. Pentoxifylline modulates intestinal tight junction signaling after burn injury: effects on myosin light chain kinase. J Trauma 2009, 66:17-24. [discussion 24-5].
14. Ma T.Y., Boivin M.A., Ye D., Pedram A., Said H.M. Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am J Physiol Gastrointest Liver Physiol 2005, 288:G422-30.
15. Kisseleva T., Song L., Vorontchikhina M., Feirt N., Kitajewski J., Schindler C. NF-kappaB regulation of endothelial cell function during LPS-induced toxemia and cancer. J Clin Invest 2006, 116:2955-2963.
16. Chen C., Jamaluddin M.S., Yan S., Sheikh-Hamad D., Yao Q. Human stanniocalcin-1 blocks TNF-alpha-induced monolayer permeability in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 2008, 28:906-912.
17. Wachtel M., Bolliger M.F., Ishihara H., Frei K., Bluethmann H., Gloor S.M. Down-regulation of occludin expression in astrocytes by tumour necrosis factor (TNF) is mediated via TNF type-1 receptor and nuclear factor-kappaB activation. J Neurochem 2001, 78:155-162.
18. Laukoetter M.G., Bruewer M., Nusrat A. Regulation of the intestinal epithelial barrier by the apical junctional complex. Curr Opin Gastroenterol 2006, 22:85-89.
19. Ye D., Ma T.Y. Cellular and molecular mechanisms that mediate basal and tumour necrosis factor-alpha-induced regulation of myosin light chain kinase gene activity. J Cell Mol Med 2008, 12:1331-1346.
20. Lewis K., Caldwell J., Phan V., Prescott D., Nazli A., Wang A., et al. Decreased epithelial barrier function evoked by exposure to metabolic stress and nonpathogenic E. coli is enhanced by TNF-alpha. Am J Physiol Gastrointest Liver Physiol 2008, 294:G669-78.
21. Kakiashvili E., Speight P., Waheed F., Seth R., Lodyga M., Tanimura S., et al. GEF-H1 mediates tumor necrosis factor-alpha-induced Rho activation and myosin phosphorylation: role in the regulation of tubular para-cellular permeability. J Biol Chem 2009, 284:11454-11466.
22. Liu Z., Li N., Neu J. Tight junctions, leaky intestines, and pediatric diseases. Acta Paediatr 2005, 94:386-393.
23. Watts T., Berti I., Sapone A., Gerarduzzi T., Not T., Zielke R., et al. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc Natl Acad Sci U S A 2005, 102:2916-2921.
24. McCarthy K.M., Skare I.B., Stankewich M.C., Furuse M., Tsukita S., Rogers R.A., et al. Occludin is a functional component of the tight junction. J Cell Sci 1996, 109(Pt 9):2287-2298.
25. Youakim A., Ahdieh M. Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am J Physiol 1999, 276:G1279-88.
26. Van Itallie C.M., Fanning A.S., Bridges A., Anderson J.M. ZO-1 stabilizes the tight junction solute barrier through coupling to the perijunctional cytoskeleton. Mol Biol Cell 2009, 20:3930-3940.
27. Yokoyama S., Tachibana K., Nakanishi H., Yamamoto Y., Irie K., Mandai K., et al. Alpha-catenin-independent recruitment of ZO-1 to nectin-based cell-cell adhesion sites through afadin. Mol Biol Cell 2001, 12:1595-1609.
28. Eiselein L., Wilson D.W., Lame M.W., Rutledge J.C. Lipolysis products from triglyceride-rich lipoproteins increase endothelial permeability, perturb zonula occludens-1 and F-actin, and induce apoptosis. Am J Physiol Heart Circ Physiol 2007, 292:H2745-53.
29. Liu L.B., Xue Y.X., Liu Y.H., Wang Y.B. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton. J Neurosci Res 2008, 86:1153-1168.
30. Kimura K., Teranishi S., Fukuda K., Kawamoto K., Nishida T. Delayed disruption of barrier function in cultured human corneal epithelial cells induced by tumor necrosis factor-alpha in a manner dependent on NF-kappaB. Invest Ophthalmol Vis Sci 2008, 49:565-571.
31. Al-Sadi R.M., Ma T.Y. IL-1beta causes an increase in intestinal epithelial tight junction permeability. J Immunol 2007, 178:4641-4649.
32. Ma T.Y., Iwamoto G.K., Hoa N.T., Akotia V., Pedram A., Boivin M.A., et al. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol 2004, 286:G367-76.
33. Kustermans G., El B.J., Piette J., Legrand-Poels S. Perturbation of actin dynamics induces NF-kappaB activation in myelomonocytic cells through an NADPH oxidase-dependent pathway. Biochem J 2005, 387:531-540.
34. Nemeth Z.H., Deitch E.A., Davidson M.T., Szabo C., Vizi E.S., Hasko G. Disruption of the actin cytoskeleton results in nuclear factor-kappaB activation and inflammatory mediator production in cultured human intestinal epithelial cells. J Cell Physiol 2004, 200:71-81.
35. Banan A., Keshavarzian A., Zhang L., Shaikh M., Forsyth C.B., Tang Y., et al. NF-kappaB activation as a key mechanism in ethanol-induced disruption of the F-actin cytoskeleton and monolayer barrier integrity in intestinal epithelium. Alcohol 2007, 41:447-460.
36. Kuhlmann C.R., Tamaki R., Gamerdinger M., Lessmann V., Behl C., Kempski O.S., et al. Inhibition of the myosin light chain kinase prevents hypoxia-induced blood-brain barrier disruption. J Neurochem 2007, 102:501-507.
37. Fanning A.S., Ma T.Y., Anderson J.M. Isolation and functional characterization of the actin binding region in the tight junction protein ZO-1. FASEB J 2002, 16:1835-1837.
38. Yu D., Marchiando A.M., Weber C.R., Raleigh D.R., Wang Y., Shen L., et al. MLCK-dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function. Proc Natl Acad Sci U S A 2010, 107:8237-8241.
39. Al-Sadi R., Ye D., Dokladny K., Ma T.Y. Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability. J Immunol 2008, 180:5653-5661.
40. Mashukova A., Wald F.A., Salas P.J. Tumor necrosis factor alpha and inflammation disrupt the polarity complex in intestinal epithelial cells by a posttranslational mechanism. Mol Cell Biol 2011, 31:756-765.
41. Ye D., Ma I., Ma T.Y. Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol 2006, 290:G496-504.